Patrizia Chiusolo

Hematology — Agostino Gemelli University Polyclinic, Italy

LeadR Profile

1 694 ScienceLeadR Reputation 1694
Network Map

Hematology

Subspecialties: Transplantation - Oncology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1998 - 2026

Source: PubMed

Catholic University of the Sacred Heart

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 489

Citations

Citations: 7 844 1st author: 38 Last author: 32 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies.
cells, hematology, lymphoma, b-cell, lymphoma, therapeutics, b-lymphocytes, prognosis, salvage therapy, car-t cell
Haematologica20260
Independent validation of the International Metabolic Prognostic Index (CAR-IMPI) in patients with aggressive diffuse large B-cell lymphoma treated with CAR-T.
cells, hematology, lymphoma, b-cell, lymphoma, lymphoma, large b-cell, diffuse, b-lymphocytes
Br J Haematol20260
Clinical Outcomes of Younger Adults With Philadelphia-Negative Acute Lymphoblastic Leukemia, Treated With A Pediatric-Like Regimen Based on the GIMEMA LAL1308 Protocol. A Campus ALL Study.
precursor cell lymphoblastic leukemia-lymphoma, hematology, leukemia, therapeutics, survival rate
Eur J Haematol20260
Early deterioration and subsequent recovery of nursing complexity after CAR-T therapy: a prospective score-based analysis.
nursing, bone marrow transplantation, recycling, therapeutics
Bone Marrow Transplant20260
InflaMix Predicts Severe CRS, ICU Admission, and Progression-Free Survival After CAR-T Therapy in LBCL.
cells, disease-free survival, hematology, progression-free survival, phenotype, therapeutics, intensive care units
Eur J Haematol20260

Clinical Studies 23

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

N/A 12
Phase 3 4
Phase 1/Phase 2 3
Phase 2 3
Phase 2/Phase 3 1

By status:

Recruiting 11
Completed 7
Not yet recruiting 2
Active not recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 13
Observational 10

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 1
multicentric5to9 1
multicentricup10 14

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Phase 1 2 study of Enzomenib (DSP 5336) in Patients with Acute leukemia
2022-502741-10-00 — hematologic neoplasms, leukemia, mutation
Phase 1/Phase 2Recruiting2024
A phase 2 multicentric study to assess the efficacy and safety of maribavir treatment in hematopoietic stem cell transplant (HSCT) recipients with cytomegalovirus (CMV) infection with a medical condition that contraindicate the administration of ganciclovir valganciclovir or foscarnet and in those who discontinued first line preemptive therapy with ganciclovir valganciclovir or foscarnet due to toxicity or intolerance
2025-521074-34-00 — cells, safety, microscopy, electron, scanning transmission, cytomegalovirus infections, ganciclovir, stem cells, cytomegalovirus, foscarnet, transplants, therapeutics, hematopoietic stem cells, antiviral agents, infections, valganciclovir
Phase 2Recruiting2026
Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History
NCT06923670 — research design, genes, thrombocythemia, essential, polycythemia vera, thrombocytosis, hematologic neoplasms, multiple endocrine neoplasia type 1, neoplasms, epithelial cell adhesion molecule, polycythemia, prevalence, myeloproliferative disorders, genes, apc, history, genes, brca1, mutation, primary myelofibrosis
N/ANot yet recruiting2025
Clinical Evaluation of the Scopio Cell Morphology Technology
NCT06574308 — cells, reading, bone marrow, blood, hematologic neoplasms, neoplasms, classification, blood cells, artificial intelligence, bone marrow cells
N/ANot yet recruiting2024
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024 — leukemia, leukemia, myeloid, acute, leukemia, myeloid, therapeutics
N/ARecruiting2024

LeadR Networks

Main global connection map